U.S. Pharmacy Industry: Economic Report and Outlook
by Adam J. Fein, Ph.D.
(52 pages, PDF, Released September 2009)
The U.S. Pharmacy Industry: Economic Report and Outlook is an invaluable planning tool for pharmaceutical manufacturers, pharmacists, employers, benefit managers, managed care executives, healthcare policy analysts, investors—anyone who wants to understand and benefit from the forces reshaping the increasingly competitive U.S. pharmacy industry. It provides the most comprehensive look at the economics and trends behind the $254 billion pharmacy industry. Read the press release.
This report was researched and written by Adam J. Fein, Ph.D., a premier industry analyst and author of the influential Drug Channels blog. It's packed with vital data and information, including 22 detailed exhibits to help you understand the industry's real economics. Dr. Fein will also tell you the seven most important trends affecting future profitability of U.S. pharmacies and give you specific projections for the industry in 2015. The U.S. Pharmacy Industry: Economic Report and Outlook report:
- Identifies the major participants and their market shares within the pharmacy industry
- Gives you the facts behind the industry’s gross margins, growth rates and profitability
- Explains the business strategies of companies such as CVS Caremark, Walgreens, and Wal-Mart
- Uncovers the secrets behind pharmacies' profits from prescriptions
- Forecasts the impact of new reimbursement metrics such as cost-plus and Average Manufacturer Price (AMP)
- Identifies the seven most important trends you must know to predict future profitability and market structure. See the list in the Table of Contents.
- Gives you specific growth projections for all major dispensing channels
No other report on the market today offers the depth, insight and analysis of the U.S. Pharmacy Industry: Economic Report and Outlook. View the Table of Contents. Order it now for immediate download as a secure PDF.
Please note that purchase of the U.S. Pharmacy Industry: Economic Report and Outlook indicates agreement with the terms and conditions of the End User License Agreement (EULA). License terms, purchaser's name/email, and a unique transaction ID will be added to the secure PDF file upon checkout. Learn more below. You must purchase the Corporate License if you want to share the report with other people in your company. We will refund duplicate purchases of a Corporate License from the same organization.
Corporate License
(Allows for use of the report by an unlimited number of employees within
the same organization or enterprise worldwide) Price:
$440.00
Single-User License
(Allows for use of the report by one individual
person) Price:
$120.00
Purchase and use of the U.S. Pharmacy Industry: Economic Report and Outlook is subject to the terms of the EULA. Pembroke Consulting, Inc., grants to Purchaser, and Purchaser hereby accepts, a limited, terminable, revocable, nontransferable, nonexclusive, nonsublicenseable license to access and use the U.S. Pharmacy Industry: Economic Report and Outlook, only in accordance with the EULA.
We offer two License Options.
- Single User License: This license allows for use of this report by one individual person identified in the upper left corner of the report. This person may use the report on any computer, and may print out the report, but may not share the report (or any information contained therein) with any other person or persons. Unless a Corporate License is purchased, a Single User License must be purchased for every person that wishes to use the report within the same organization or enterprise. Customers who infringe these license terms are liable for a Corporate License fee.
- Corporate License: This license allows for use of a report by an unlimited number of employees within the same organization or enterprise worldwide as the person identified in the upper left corner of the report. Each of the employees within this organization or enterprise may use the report on any computer, and may print out the report, but may not share the report (or any information contained therein) with any other person or persons outside of the enterprise or organization. We will refund duplicate purchases of a Corporate License from the same organization.
The U.S. Pharmacy Industry: Economic Report and Outlook is protected by copyright law. Unauthorized reproduction or distribution of this report, or any portion of it, may result in severe civil and criminal penalties, and will be prosecuted to the maximum extent of the law.